tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALLO Stock Latest News

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Press ReleasesAllogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
12d ago
ALLO
Allogene awarded $15M grant from CIRM to support ALLO-316 development
PremiumThe Fly
Allogene awarded $15M grant from CIRM to support ALLO-316 development
12d ago
ALLO
IO Biotech appoints Shamsaei as SVP, Commercial Development
PremiumThe Fly
IO Biotech appoints Shamsaei as SVP, Commercial Development
23d ago
ALLO
IOBT
Allogene Therapeutics Announces Q2 Investor Conference Participation
PremiumPress Releases
Allogene Therapeutics Announces Q2 Investor Conference Participation
29d ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe Fly
Allogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe FlyAllogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe Fly
Allogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics’ Stability Threatened by Banking Sector Turmoil
PremiumCompany Announcements
Allogene Therapeutics’ Stability Threatened by Banking Sector Turmoil
2M ago
ALLO
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
2M ago
AZN
BMY
Allogene Therapeutics files $500M mixed securities shelf
PremiumThe Fly
Allogene Therapeutics files $500M mixed securities shelf
2M ago
ALLO
Allogene Therapeutics sees $190M reduction in cash in 2024
PremiumThe Fly
Allogene Therapeutics sees $190M reduction in cash in 2024
2M ago
ALLO
Allogene Therapeutics reports Q4 EPS (51c), consensus (45c)
PremiumThe Fly
Allogene Therapeutics reports Q4 EPS (51c), consensus (45c)
2M ago
ALLO
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
PremiumPress ReleasesAllogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
2M ago
ALLO
Allogene, Arbor enter global gene editing license agreement
PremiumThe Fly
Allogene, Arbor enter global gene editing license agreement
2M ago
ALLO
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
PremiumPress Releases
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
2M ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe Fly
Allogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe Fly
Allogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
PremiumPress Releases
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
2M ago
ALLO
Allogene Therapeutics management to meet with Truist
PremiumThe Fly
Allogene Therapeutics management to meet with Truist
2M ago
ALLO
Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
PremiumPress ReleasesAllogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
2M ago
ALLO
Is ALLO a Buy, Before Earnings?
PremiumPre-Earnings
Is ALLO a Buy, Before Earnings?
2M ago
ALLO
Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
PremiumPress Releases
Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
3M ago
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >